Targeting ANXA3 in combination with sorafenib for the treatment of hepatocellular carcinoma

被引：0
|
作者：
Tong, Man
Luk, Steve
Che, Noelia
Ding, Jin
Lee, Terence K. W.
Ma, Stephanie
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-3146
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3146
引用
收藏
页数：2
相关论文
共 50 条
  • [21] THE COMBINATION EVEROLIMUS (RAD001) PLUS SORAFENIB IS SUPERIOR TO SORAFENIB MONOTHERAPY IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA
    Piguet, A. -C.
    Radojevic, V.
    Afthinos, M.
    Hora, C.
    Ledermann, M.
    Saar, B.
    Dufour, J. -F.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S199 - S199
  • [22] Investigation of new treatment option for hepatocellular carcinoma: a combination of sorafenib with usnic acid
    Yurdacan, Beste
    Egeli, Unal
    Eskiler, Gamze Guney
    Eryilmaz, Isil Ezgi
    Cecener, Gulsah
    Tunca, Berrin
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2019, 71 (07) : 1119 - 1132
  • [23] Effectiveness of sorafenib in the treatment of hepatocellular carcinoma
    Salamanca, P.
    Magalhaes, H.
    Carneiro, F.
    Marques, D.
    Faustino, C.
    Sousa, N.
    Machado, M.
    Ferreira, P.
    Raimundo, A.
    Fragoso, M.
    Lara Santos, L.
    Pereira, D.
    ANNALS OF ONCOLOGY, 2016, 27 : 52 - 52
  • [24] Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma
    Kane, Robert C.
    Farrell, Ann T.
    Madabushi, Rajanikanth
    Booth, Brian
    Chattopadhyay, Somesh
    Sridhara, Rajeshwari
    Justice, Robert
    Pazdur, Richard
    ONCOLOGIST, 2009, 14 (01): : 95 - 100
  • [25] Sorafenib for the treatment of unresectable hepatocellular carcinoma
    Furuse, Junji
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (04): : 779 - 788
  • [26] Sorafenib for the treatment of advanced hepatocellular carcinoma
    Connock, M.
    Round, J.
    Bayliss, S.
    Tubeuf, S.
    Greenheld, W.
    Moore, D.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 17 - 21
  • [27] ANXA3/JNK Signaling Promotes Self-Renewal and Tumor Growth, and Its Blockade Provides a Therapeutic Target for Hepatocellular Carcinoma
    Tong, Man
    Fung, Tsun-Ming
    Luk, Steve T.
    Ng, Kai-Yu
    Lee, Terence K.
    Lin, Chi-Ho
    Yam, Judy W.
    Chan, Kwok Wah
    Ng, Fai
    Zheng, Bo-Jian
    Yuan, Yun-Fei
    Xie, Dan
    Lo, Chung-Mau
    Man, Kwan
    Guan, Xin-Yuan
    Ma, Stephanie
    STEM CELL REPORTS, 2015, 5 (01): : 45 - 59
  • [28] Advanced hepatocellular carcinoma treated by a combination of sorafenib and radiotherapy
    Yang, Bi-Ling
    Yeh, Chun
    Hsu, Chung-Te
    Chang, Tien-Yu
    Wang, Chung-Yih
    ADVANCES IN DIGESTIVE MEDICINE, 2014, 1 (01) : 25 - 29
  • [29] Combination of transarterial therapy with sorafenib for hepatocellular carcinoma.
    Cabrera, R.
    Pannu, D. S.
    Caridi, J.
    Firpi, R.
    Soldevila-Pico, C.
    Morelli, G.
    Clark, V.
    George, T. J.
    Nelson, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [30] Discovering the effect of combination of celecoxib and sorafenib on hepatocellular carcinoma
    Gu, Wang
    Zeng, Dongyun
    Zhang, Chao
    DISCOVER ONCOLOGY, 2024, 15 (01)
12345